• Oraya Therapeutics
• News and Events

An Exciting New Treatment Option

Please check this section frequently for updates on news announcements, industry events, and for our latest media resources.

Upcoming Events

May 20, 2013 | Retina Day
Royal College of Ophthalmologists Annual Congress 2013
Liverpool, United Kingdom

May 21-23, 2013 | Oraya Therapeutics Booth # 19
Royal College of Ophthalmologists Annual Congress 2013
Liverpool, United Kingdom

Latest Press Releases

Thursday, April 18, 2013 | Oraya Therapeutics, Inc. today announced that results of its INTREPID study evaluating the safety and efficacy of Oraya Therapy™ Stereotactic Radiotherapy…More >

Thursday, April 4, 2013 | New Therapy for Wet AMD Introduced in Switzerland by Oraya^® Therapeutics and EyeRAD…More >

Wednesday, February 27, 2013 | Oraya Therapy™ Continues to Show Efficacy for Wet Age-Related Macular Degeneration…More >

Latest News

April 18, 2013 | The Wall Street Journal
Oraya Therapeutics’ INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology

April 1, 2013 | New Retina MD
Radiation Therapy for Neovascular Age-related Macular Degeneration

March 4, 2013 | Mail Online
The X-ray beam that could end painful jabs for aging eyes

March 1, 2013 | Ophthalmology Times
INTREPID identifies ‘best responders’: Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD

February 27, 2013 | Insight Radio
Revolutionary Treatment for AMD Launched

February 26, 2013 | Yahoo!7 News
Hope for eye disease sufferers

February 25, 2013 | ITV
New hope for macular degeneration

February 11, 2013 | SMT Online
OnCore Opens Medical Center-of-Excellence

Presented at 2012 AAO-APAO Joint Meeting
IRay Plus Anti-VEGF Treatment for Patients with Wet Age-Related Macular Degeneration: The INTREPID Trial of Stereotactic Radiotherapy for Choroidal Neovascularization in AMD
Peter K. Kaiser, MD View Video >